Mangalore Refinery and Petrochemicals (500109) Q1 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 25/26 earnings summary
6 Jan, 2026Executive summary
Q1 FY26 saw lower throughput at 3.52 MMT due to a planned plant turnaround, with April setting a record 1.51 MMT processed once all units were online.
Operational challenges and regulatory provisions led to a PAT loss of INR 272 crores, considered transient.
Board approved unaudited financial results for Q1 FY26 and appointed a new cost auditor for FY 2025-26.
Amendment to the Object Clause of the Memorandum of Association was recommended for shareholder approval.
All major units are now operational, positioning the refinery for higher throughput and improved performance in upcoming quarters.
Financial highlights
Standalone revenue from operations for Q1 FY26 was INR 20,988.03 crores, reflecting lower throughput and a 20% YoY drop in benchmark crude prices, with an 8% sequential decline.
Standalone net loss for Q1 FY26 was INR 271.97 crores, compared to a net profit of INR 65.57 crores in Q1 FY25.
Gross refining margin (GRM) averaged $3.88/bbl, down from $4.70/bbl YoY and $6.23/bbl QoQ.
EBITDA stood at INR 218 crores; depreciation and finance costs were INR 363 crores and INR 255 crores, respectively.
Operating expenses were INR 601 crores, slightly lower QoQ due to the shutdown.
Outlook and guidance
Throughput for Q2 is expected above 4.3 MMT, with GRMs projected in the high single digits, supported by stronger middle distillate cracks.
If crude prices remain stable, financial performance is expected to rebound in the coming quarters.
Annual CAPEX is projected at around INR 1,000 crores, including shutdown expenses.
Management assessed the impact of global geopolitical events and found no significant effect on asset carrying values.
Latest events from Mangalore Refinery and Petrochemicals
- EBITDA, revenue, and profit surged; retail and bio-ATF growth support a strong outlook.500109
Q3 25/2619 Jan 2026 - Strong Q4 margins and throughput, but FY25 profit dropped and no dividend was declared.500109
Q4 24/257 Jan 2026 - Q2 and H1 FY26 saw strong profit recovery, margin gains, and lower leverage.500109
Q2 25/2626 Nov 2025 - Revenue up but net profit down sharply; stable ratios and no export excise duty this quarter.500109
Q1 24/251 Sep 2025 - Q2 FY25 saw a sharp swing to net loss despite higher revenue, with key ratios weakening.500109
Q2 24/251 Sep 2025 - Q3 FY25 saw a return to profitability with net profit of ₹309.30 crore and improved margins.500109
Q3 24/251 Sep 2025